Published in Anticancer Res on August 27, 2004
Nab-paclitaxel efficacy in the orthotopic model of human breast cancer is significantly enhanced by concurrent anti-vascular endothelial growth factor A therapy. Neoplasia (2008) 1.08
Synergy of nab-paclitaxel and bevacizumab in eradicating large orthotopic breast tumors and preexisting metastases. Neoplasia (2011) 1.02
Nanoparticle-based targeted therapeutics in head-and-neck cancer. Int J Med Sci (2015) 0.79
Bevacizumab enhances chemosensitivity of hepatocellular carcinoma to adriamycin related to inhibition of survivin expression. J Cancer Res Clin Oncol (2010) 0.79
Targeted delivery of albumin bound paclitaxel in the treatment of advanced breast cancer. Onco Targets Ther (2009) 0.79
TNFR-1 on tumor cells contributes to the sensitivity of fibrosarcoma to chemotherapy. Protein Cell (2013) 0.75
Patients with hereditary hemorrhagic telangiectasia have increased plasma levels of vascular endothelial growth factor and transforming growth factor-beta1 as well as high ALK1 tissue expression. Haematologica (2005) 1.96
Is the p53 inactivation frequency in squamous cell carcinomas of the head and neck underestimated? Analysis of p53 exons 2-11 and human papillomavirus 16/18 E6 transcripts in 123 unselected tumor specimens. Cancer Res (2003) 1.79
Serum levels of interleukin-6 in patients with primary head and neck squamous cell carcinoma. Anticancer Res (2005) 1.63
Radiofrequency surgery of the soft palate in the treatment of snoring. A placebo-controlled trial. Sleep (2005) 1.61
Tonsillectomy with Uvulopalatopharyngoplasty in Obstructive Sleep Apnea. Dtsch Arztebl Int (2016) 1.47
Endoscopic diverticulotomy of Zenker's diverticulum: management and complications. Dysphagia (2002) 1.45
Functional short- and long-term effects of nasal CPAP with and without humidification on the ciliary function of the nasal respiratory epithelium. Sleep Breath (2013) 1.44
Hereditary hemorrhagic telangiectasia: an update on clinical manifestations and diagnostic measures. Wien Klin Wochenschr (2006) 1.37
Tonsillectomy in children. Dtsch Arztebl Int (2008) 1.28
Does drug-induced sleep endoscopy change the treatment concept of patients with snoring and obstructive sleep apnea? Sleep Breath (2012) 1.21
Changes in daytime sleepiness, quality of life, and objective sleep patterns in seasonal allergic rhinitis: a controlled clinical trial. J Allergy Clin Immunol (2004) 1.16
Rhinophyma: diagnosis and treatment options for a disfiguring tumor of the nose. Ann Plast Surg (2008) 1.15
A common curriculum in Europe for ORL-HNS specialization and subspecialist training programs: we are on the right way! Eur Arch Otorhinolaryngol (2009) 1.11
Identification of valid reference genes during the differentiation of human myoblasts. BMC Mol Biol (2009) 1.09
Integrin expression in stem cells from bone marrow and adipose tissue during chondrogenic differentiation. Int J Mol Med (2008) 1.08
EGFR antisense treatment of human HNSCC cell lines down-regulates VEGF expression and endothelial cell migration. Int J Oncol (2002) 1.02
Axonemal localization of the dynein component DNAH5 is not altered in secondary ciliary dyskinesia. Pediatr Res (2006) 0.97
A mobile olfactometer for fMRI-studies. J Neurosci Methods (2012) 0.97
Angiogenesis in hereditary hemorrhagic telangiectasia: VEGF165 plasma concentration in correlation to the VEGF expression and microvessel density. Int J Mol Med (2005) 0.97
ENT manifestations in patients with primary ciliary dyskinesia: prevalence and significance of otorhinolaryngologic co-morbidities. Eur Arch Otorhinolaryngol (2010) 0.97
Auricular keloids: combined therapy with a new pressure device. Arch Facial Plast Surg (2011) 0.96
Apoptosis in bone for tissue engineering. Arch Med Res (2008) 0.94
In vitro analysis of integrin expression during chondrogenic differentiation of mesenchymal stem cells and chondrocytes upon dedifferentiation in cell culture. Int J Mol Med (2006) 0.93
Sublingual allergen-specific immunotherapy adjuvanted with monophosphoryl lipid A: a phase I/IIa study. Int Arch Allergy Immunol (2010) 0.93
Characterization of human myoblast cultures for tissue engineering. Int J Mol Med (2008) 0.92
Mediators of inflammation in the early and the late phase of allergic rhinitis. Curr Opin Allergy Clin Immunol (2004) 0.92
Expression of collagen and fiber-associated proteins in human septal cartilage during in vitro dedifferentiation. Int J Mol Med (2004) 0.92
Arousal responses to olfactory or trigeminal stimulation during sleep. Sleep (2007) 0.92
Current advances in the basic research and clinical management of sinonasal inverted papilloma (review). Oncol Rep (2007) 0.90
Volumetric tissue reduction in radiofrequency surgery of the tongue base. Otolaryngol Head Neck Surg (2005) 0.90
The effect of hyoid suspension in a multilevel surgery concept for obstructive sleep apnea. Otolaryngol Head Neck Surg (2006) 0.90
Common carotid artery dissection: a rare cause for cervical pain. J Laryngol Otol (2002) 0.89
Chondrosarcoma of the larynx and review of the literature. Anticancer Res (2007) 0.88
Advances in skeletal muscle tissue engineering. In Vivo (2007) 0.88
Retracted In vitro analysis of integrin expression in stem cells from bone marrow and cord blood during chondrogenic differentiation. J Cell Mol Med (2008) 0.87
Plasma level and tissue expression of angiogenic factors in patients with hereditary hemorrhagic telangiectasia. Int J Mol Med (2005) 0.87
Management of radiation-induced tracheocutaneous tissue defects by transplantation of an ear cartilage graft and deltopectoral flap. Auris Nasus Larynx (2005) 0.87
A mandibular advancement device for the ENT office to treat obstructive sleep apnea. Otolaryngol Head Neck Surg (2007) 0.87
Tongue base reduction with temperature-controlled radiofrequency volumetric tissue reduction for treatment of obstructive sleep apnea syndrome. Acta Otolaryngol (2002) 0.87
In vitro analysis of radiation-induced dermal wounds. Otolaryngol Head Neck Surg (2010) 0.87
Long-term results of palatal implants for primary snoring. Otolaryngol Head Neck Surg (2005) 0.87
Severe vision and hearing impairment and successful aging: a multidimensional view. Gerontologist (2013) 0.87
Topical estrogens combined with argon plasma coagulation in the management of epistaxis in hereditary hemorrhagic telangiectasia. Ann Otol Rhinol Laryngol (2002) 0.86
The platelet-derived growth factor receptor as a target for vascular endothelial growth factor-mediated anti-angiogenetic therapy in head and neck cancer. Int J Oncol (2009) 0.86
Evaluation of serum-free culture conditions for primary human nasal epithelial cells. Int J Hyg Environ Health (2002) 0.86
CD44 as a stem cell marker in head and neck squamous cell carcinoma. Oncol Rep (2011) 0.86
Palatal implants for primary snoring: short-term results of a new minimally invasive surgical technique. Otolaryngol Head Neck Surg (2005) 0.85
Videoendoscopic Assessment of Uncommon Sites of Upper Airway Obstruction during Sleep. Sleep Breath (2000) 0.85
Pharmacological management of allergic rhinitis in the elderly: safety issues with oral antihistamines. Drugs Aging (2005) 0.85
Ossifying haemangioma of the frontal sinus. ORL J Otorhinolaryngol Relat Spec (2004) 0.85
Chemosensory event-related potentials during sleep--a pilot study. Neurosci Lett (2006) 0.85
Altered expression of cell cycle regulators p21, p27, and p53 in tumors of salivary glands and paranasal sinuses. Oncol Rep (2005) 0.84
TGF-ß1 antisense impacts the SMAD signalling system in fibroblasts from keloid scars. Anticancer Res (2010) 0.84
Does the genotype of HHT patients with mutations of the ENG and ACVRL1 gene correlate to different expression levels of the angiogenic factor VEGF? Int J Mol Med (2008) 0.84
Immunohistochemical analysis of radiation-induced non-healing dermal wounds of the head and neck. In Vivo (2005) 0.84
Radiofrequency surgery of the soft palate in the treatment of snoring: a review of the literature. Sleep (2004) 0.83
Targeting TGF-beta in human keratinocytes and its potential role in wound healing. Int J Mol Med (2004) 0.83
Bipolar radiofrequency volumetric tissue reduction of the inferior turbinates: evaluation of short-term efficacy in a prospective, randomized, single-blinded, placebo-controlled crossover trial. Eur Arch Otorhinolaryngol (2012) 0.83
Intratumoral genomic heterogeneity in advanced head and neck cancer detected by comparative genomic hybridization. Cancer Genet Cytogenet (2003) 0.83
Anatomic changes after hyoid suspension for obstructive sleep apnea: an MRI study. Otolaryngol Head Neck Surg (2005) 0.83
Information processing during sleep: the effect of olfactory stimuli on dream content and dream emotions. J Sleep Res (2009) 0.83
Safety of cold ablation (coblation) in the treatment of tonsillar hypertrophy of the tongue base. Eur Arch Otorhinolaryngol (2014) 0.83
Safety aspects of Cluster immunotherapy with semi-depot allergen extracts in seasonal allergic rhinoconjunctivitis. Eur Arch Otorhinolaryngol (2010) 0.82
Impact of static magnetic fields on human myoblast cell cultures. Int J Mol Med (2011) 0.82
Influence of interleukin-13 on beta-catenin levels in eosinophilic chronic rhinosinusitis cell culture. Int J Mol Med (2008) 0.81
Ossifying fibromyxoid tumor of the nasal septum. Auris Nasus Larynx (2006) 0.81
Twenty-four-hour and annual variation in onset of epistaxis in Osler disease. Chronobiol Int (2007) 0.81
The surgical treatment of sleep-related upper airway obstruction. Dtsch Arztebl Int (2011) 0.80
Alcohol-related diseases of the mouth and throat. Best Pract Res Clin Gastroenterol (2003) 0.80
Multilevel surgery for obstructive sleep apnea: short-term results. Otolaryngol Head Neck Surg (2006) 0.80
Tissue engineering with chondrocytes and function of the extracellular matrix (Review). Int J Mol Med (2004) 0.80
p53 codon 72 polymorphic variants, loss of allele-specific transcription, and human papilloma virus 16 and/or 18 E6 messenger RNA expression in squamous cell carcinomas of the head and neck. Cancer Epidemiol Biomarkers Prev (2004) 0.80
Down-regulation of MMP-2 expression due to inhibition of receptor tyrosine kinases by imatinib and carboplatin in HNSCC. Oncol Rep (2011) 0.80
Small molecule-based chemotherapeutic approach in p16-positive and -negative HNSCC in vitro. Anticancer Res (2013) 0.80
TGF-beta antisense oligonucleotides reduce mRNA expression of matrix metalloproteinases in cultured wound-healing-related cells. Int J Mol Med (2005) 0.80
Taste disorders after tonsillectomy: a long-term follow-up. Laryngoscope (2012) 0.79
Recent developments in the treatment of obstructive sleep apnea. Am J Respir Med (2003) 0.79
Sinonasal malignancy: what's new? ORL J Otorhinolaryngol Relat Spec (2004) 0.79
Abrogation of VEGF expression in human head and neck squamous cell carcinoma decreases angiogenic activity in vitro and in vivo. Int J Oncol (2003) 0.79
Pharyngeal chemosensitivity in patients with obstructive sleep apnea and healthy subjects. Chem Senses (2013) 0.79
Mutation analysis of "Endoglin" and "Activin receptor-like kinase" genes in German patients with hereditary hemorrhagic telangiectasia and the value of rapid genotyping using an allele-specific PCR-technique. BMC Med Genet (2009) 0.79
Tumor-associated antigens as possible targets for immune therapy in head and neck cancer: comparative mRNA expression analysis of RAGE and GAGE genes. Acta Otolaryngol (2002) 0.79
IL-6 antisense-mediated growth inhibition in a head and neck squamous cell carcinoma cell line. In Vivo (2011) 0.78
Intratumoral genomic heterogeneity in advanced head and neck cancer detected by comparative genomic hybridization. Adv Otorhinolaryngol (2005) 0.78
In vitro effects of doxycycline on inflammatory cytokines and gelatinases in chronic rhinosinusitis. In Vivo (2012) 0.78
Combined radiofrequency surgery of the tongue base and soft palate in obstructive sleep apnoea. Acta Otolaryngol (2004) 0.78
Evaluating the upper airway with standardized magnetic resonance imaging. Laryngoscope (2002) 0.78
Tissue engineering in head and neck reconstructive surgery: what type of tissue do we need? Eur Arch Otorhinolaryngol (2007) 0.78
Evaluation of the effects of different culture media on the myogenic differentiation potential of adipose tissue- or bone marrow-derived human mesenchymal stem cells. Int J Mol Med (2013) 0.78
Combined radiofrequency assisted uvulopalatoplasty in the treatment of snoring. Eur Arch Otorhinolaryngol (2008) 0.78